skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Therapy of autoimmune bullous diseases

(2124) Views  (614) Full article downloads

Authors: Diya F Mutasim

Published Date February 2007 Volume 2007:3(1) Pages 29 - 40
DOI: http://dx.doi.org/10.2147/TCRM.S

Diya F Mutasim

Department of Dermatology, University of Cincinnati College of Medicine, Cincinnati, OH, USA

Abstract: Autoimmune bullous diseases result from an immune response to molecular components of the desmosome or basement membrane. Bullous diseases are associated with a high degree of morbidity and occasional mortality. Therapy of bullous diseases consists of suppressing the immune system, controlling inflammation and improving healing of erosions. The therapeutic agents used in the treatment of bullous diseases may be associated with high morbidity and occasional mortality. Successful treatment requires understanding of the pathophysiology of the disease process and the pharmacology of the drugs being used.  

Keywords: autoimmune, bullous, therapy








Readers of this article also read:

Docetaxel for the post-surgery treatment of patients with node-positive breast cancer
Sevelamer as a phosphate binder in adult hemodialysis patients: an evidence-based review of its therapeutic value
Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect
Information technology in pharmacovigilance: Benefits, challenges, and future directions from industry perspectives
Functional mobility and balance in community-dwelling elderly submitted to multisensory versus strength exercises
Clinicoradiological features of recurrent ischemic stroke: healthcare for poststroke patients
Retinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomography
Wearing facemasks when performing lumbar punctures: a snapshot of current practice amongst trainee doctors
Corrigendum
Corrigendum